{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:56:11Z","timestamp":1790916971438,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20187-1","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:15:58Z","timestamp":1784499358000},"page":"9710-9718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Locoregional Treatment in Non-Progressive De Novo Metastatic Breast Cancer under Systemic Treatment: A Randomized Controlled Trial (LTMBC)"],"prefix":"10.1245","volume":"33","author":[{"given":"Ramesh","family":"Omranipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newsha","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Mirzania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatereh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3150-9400","authenticated-orcid":false,"given":"Mahtab","family":"Vasigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"20187_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72:524\u201341. https:\/\/doi.org\/10.3322\/caac.21754.","journal-title":"CA Cancer J Clin."},{"key":"20187_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.breast.2014.08.009","volume":"23","author":"F Cardoso","year":"2014","unstructured":"Cardoso F, Costa A, Norton L, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23:489\u2013502. https:\/\/doi.org\/10.1016\/j.breast.2014.08.009.","journal-title":"Breast."},{"key":"20187_CR3","doi-asserted-by":"publisher","first-page":"pky062","DOI":"10.1093\/jncics\/pky062","volume":"2","author":"JL Caswell-Jin","year":"2018","unstructured":"Caswell-Jin JL, Plevritis SK, Tian L, et al. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2018;2:pky062. https:\/\/doi.org\/10.1093\/jncics\/pky062.","journal-title":"JNCI Cancer Spectr."},{"key":"20187_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1067\/msy.2002.127544","volume":"132","author":"SA Khan","year":"2002","unstructured":"Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620\u20137. https:\/\/doi.org\/10.1067\/msy.2002.127544.","journal-title":"Surgery."},{"key":"20187_CR5","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1245\/s10434-007-9438-0","volume":"14","author":"J Gnerlich","year":"2007","unstructured":"Gnerlich J, Jeffe DB, Deshpande AD, et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988\u20132003 SEER data. Ann Surg Oncol. 2007;14:2187\u201394. https:\/\/doi.org\/10.1245\/s10434-007-9438-0.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1245\/ASO.2006.03.033","volume":"13","author":"GV Babiera","year":"2006","unstructured":"Babiera GV, Rao R, Feng L, Meric-Bernstam F, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776\u201382. https:\/\/doi.org\/10.1245\/ASO.2006.03.033.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.breast.2011.06.005","volume":"20","author":"JA P\u00e9rez-Fidalgo","year":"2011","unstructured":"P\u00e9rez-Fidalgo JA, Pimentel P, Caballero A, et al. Removal of primary tumor improves survival in metastatic breast cancer: does timing of surgery influence outcomes? Breast. 2011;20:548\u201354. https:\/\/doi.org\/10.1016\/j.breast.2011.06.005.","journal-title":"Breast."},{"key":"20187_CR8","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/bjs.7650","volume":"98","author":"NB Pathy","year":"2011","unstructured":"Pathy NB, Verkooijen H, Taib N, Hartman M, Yip C. Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg. 2011;98:1566\u201372. https:\/\/doi.org\/10.1002\/bjs.7650.","journal-title":"Br J Surg."},{"key":"20187_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-008-0101-7","volume":"115","author":"AC Bafford","year":"2009","unstructured":"Bafford AC, Burstein HJ, Barkley CR, et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009;115:7\u201312. https:\/\/doi.org\/10.1007\/s10549-008-0101-7.","journal-title":"Breast Cancer Res Treat."},{"key":"20187_CR10","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1245\/s10434-007-9527-0","volume":"14","author":"RC Fields","year":"2007","unstructured":"Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14:3345\u201351. https:\/\/doi.org\/10.1245\/s10434-007-9527-0.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/cncr.24873","volume":"116","author":"HB Neuman","year":"2010","unstructured":"Neuman HB, Morrogh M, Gonen M, et al. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116:1226\u201333. https:\/\/doi.org\/10.1002\/cncr.24873.","journal-title":"Cancer."},{"key":"20187_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.ejso.2009.03.012","volume":"35","author":"J Ruiterkamp","year":"2009","unstructured":"Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35:1146\u201351. https:\/\/doi.org\/10.1016\/j.ejso.2009.03.012.","journal-title":"Eur J Surg Oncol."},{"key":"20187_CR13","first-page":"827","volume":"21","author":"T Shien","year":"2009","unstructured":"Shien T, Kinoshita T, Shimizu C, et al. Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep. 2009;21:827\u201332.","journal-title":"Oncol Rep."},{"key":"20187_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejso.2011.10.004","volume":"38","author":"ZM Rashaan","year":"2012","unstructured":"Rashaan ZM, Bastiaannet E, Portielje JE, et al. Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery. Eur J Surg Oncol. 2012;38:52\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2011.10.004.","journal-title":"Eur J Surg Oncol."},{"key":"20187_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10549-011-1648-2","volume":"129","author":"L Dominici","year":"2011","unstructured":"Dominici L, Najita J, Hughes M, et al. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Rres Treat. 2011;129:459\u201365. https:\/\/doi.org\/10.1007\/s10549-011-1648-2.","journal-title":"Breast Cancer Rres Treat."},{"key":"20187_CR16","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1245\/s10434-013-2998-2","volume":"20","author":"E Harris","year":"2013","unstructured":"Harris E, Barry M, Kell MR. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol. 2013;20:2828\u201334. https:\/\/doi.org\/10.1245\/s10434-013-2998-2.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-009-0670-0","volume":"120","author":"J Ruiterkamp","year":"2010","unstructured":"Ruiterkamp J, Voogd AC, Bosscha K, Tjan-Heijnen VC, Ernst MF. Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Rres Treat. 2010;120:9\u201316. https:\/\/doi.org\/10.1007\/s10549-009-0670-0.","journal-title":"Breast Cancer Rres Treat."},{"key":"20187_CR18","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1007\/s12032-012-0310-0","volume":"29","author":"F Petrelli","year":"2012","unstructured":"Petrelli F, Barni S. Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression. Med Oncol. 2012;29:3282\u201390. https:\/\/doi.org\/10.1007\/s12032-012-0310-0.","journal-title":"Med Oncol."},{"key":"20187_CR19","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/S1470-2045(15)00135-7","volume":"16","author":"R Badwe","year":"2015","unstructured":"Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16:1380\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(15)00135-7.","journal-title":"Lancet Oncol."},{"key":"20187_CR20","doi-asserted-by":"crossref","unstructured":"Soran A, Ozmen V, Ozbas S, et al. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (protocol MF07-01). Am J Clin Oncol. 2016.","DOI":"10.1200\/JCO.2016.34.15_suppl.1005"},{"key":"20187_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1200\/JCO.21.02006","volume":"40","author":"SA Khan","year":"2022","unstructured":"Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol. 2022;40:978\u201387. https:\/\/doi.org\/10.1200\/JCO.21.02006.","journal-title":"J Clin Oncol."},{"key":"20187_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41416-025-03097-z","volume":"133","author":"T Shien","year":"2025","unstructured":"Shien T, Hara F, Aogi K, et al. Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial: clinical studies. Br J Cancer. 2025;133:625\u201332. https:\/\/doi.org\/10.1038\/s41416-025-03097-z.","journal-title":"Br J Cancer."},{"key":"20187_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12885-020-06894-2","volume":"20","author":"V Bjelic-Radisic","year":"2020","unstructured":"Bjelic-Radisic V, Fitzal F, Knauer M, et al. Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial. BMC Cancer. 2020;20:392. https:\/\/doi.org\/10.1186\/s12885-020-06894-2.","journal-title":"BMC Cancer."},{"key":"20187_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2482-12-5","volume":"12","author":"J Ruiterkamp","year":"2012","unstructured":"Ruiterkamp J, Voogd AC, Tjan-Heijnen VC, et al. SUBMIT: systemic therapy with or without upfront surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg. 2012;12:5. https:\/\/doi.org\/10.1186\/1471-2482-12-5.","journal-title":"BMC Surg."},{"key":"20187_CR25","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/S0960-9776(23)00332-6","volume":"68","author":"R Omranipour","year":"2023","unstructured":"Omranipour R, Shahi F, Mirzania M, et al. P214: the role of locoregional treatment in non-progressive de novo multi-metastatic breast cancer, a randomized controlled trial. Breast. 2023;68:S101.","journal-title":"Breast."},{"key":"20187_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3892\/mco.2016.778","volume":"4","author":"H Headon","year":"2016","unstructured":"Headon H, Wazir U, Kasem A, Mokbel K. Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: a systematic review and meta-analysis. Mol Clin Oncol. 2016;4:863\u20137. https:\/\/doi.org\/10.3892\/mco.2016.778.","journal-title":"Mol Clin Oncol."},{"key":"20187_CR27","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ejso.2018.08.002","volume":"44","author":"W Xiao","year":"2018","unstructured":"Xiao W, Zou Y, Zheng S, et al. Primary tumor resection in stage IV breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2018;44:1504\u201312. https:\/\/doi.org\/10.1016\/j.ejso.2018.08.002.","journal-title":"Eur J Surg Oncol."},{"key":"20187_CR28","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1038\/s41598-020-59908-1","volume":"10","author":"R Gera","year":"2020","unstructured":"Gera R, Chehade HE, Wazir U, et al. Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: a meta-analysis. Sci Rep. 2020;10:2952. https:\/\/doi.org\/10.1038\/s41598-020-59908-1.","journal-title":"Sci Rep."},{"key":"20187_CR29","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/j.clbc.2019.12.010","volume":"20","author":"KN Kim","year":"2020","unstructured":"Kim KN, Qureshi MM, Huang D, et al. The impact of locoregional treatment on survival in patients with metastatic breast cancer: a national cancer database analysis. Clin Breast Cancer. 2020;20:e200\u201313. https:\/\/doi.org\/10.1016\/j.clbc.2019.12.010.","journal-title":"Clin Breast Cancer."},{"key":"20187_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1200\/JCO.2016.34.15_suppl.1006","volume":"34","author":"TA King","year":"2016","unstructured":"King TA, Lyman J, Gonen M, et al. A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013). J Clin Oncol. 2016;34:1006.","journal-title":"J Clin Oncol."},{"key":"20187_CR31","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.ctrv.2024.102784","volume":"129","author":"W Zhou","year":"2024","unstructured":"Zhou W, Yue Y, Xiong J, Li W, Zeng X. The role of locoregional surgery in de novo stage IV breast cancer: a meta-analysis of randomized controlled trials. Cancer Treat Rev. 2024;129:102784. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102784.","journal-title":"Cancer Treat Rev."},{"key":"20187_CR32","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1245\/s10434-021-09650-3","volume":"28","author":"Y Yu","year":"2021","unstructured":"Yu Y, Hong H, Wang Y, et al. Clinical evidence for locoregional surgery of the primary tumor in patients with de novo stage IV breast cancer. Ann Surg Oncol. 2021;28:5059\u201370. https:\/\/doi.org\/10.1245\/s10434-021-09650-3.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jamcollsurg.2021.08.686","volume":"233","author":"A Soran","year":"2021","unstructured":"Soran A, Ozmen V, Ozbas S, et al. Primary surgery with systemic therapy in patients with de novo stage IV breast cancer: 10-year follow-up; protocol MF07-01 randomized clinical trial. J Am Coll Surg. 2021;233:742\u201351. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2021.08.686.","journal-title":"J Am Coll Surg."},{"key":"20187_CR34","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1245\/s10434-020-08310-2","volume":"27","author":"R Mudgway","year":"2020","unstructured":"Mudgway R, Villanueva CCP, Lin AC, et al. The impact of primary tumor surgery on survival in HER2-positive stage IV breast cancer patients in the current era of targeted therapy. Ann Surg Oncol. 2020;27:2711\u201320. https:\/\/doi.org\/10.1245\/s10434-020-08310-2.","journal-title":"Ann Surg Oncol."},{"key":"20187_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1245\/s10434-020-08310-2","volume":"159","author":"K Harano","year":"2016","unstructured":"Harano K, Lei X, Gonzalez-Angulo AM, Murthy RK, et al. Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer. Breast Cancer Res Treat. 2016;159:367\u201374. https:\/\/doi.org\/10.1245\/s10434-020-08310-2.","journal-title":"Breast Cancer Res Treat."},{"key":"20187_CR36","doi-asserted-by":"publisher","first-page":"115475","DOI":"10.1016\/j.ejca.2025.115475","volume":"222","author":"N Ding","year":"2025","unstructured":"Ding N, Hermans KE, van Nijnatten TJ, et al. Overall survival of patients with de novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: a population-based cohort study of systemically treated patients. Eur J Cancer. 2025;222:115475. https:\/\/doi.org\/10.1016\/j.ejca.2025.115475.","journal-title":"Eur J Cancer."},{"key":"20187_CR37","doi-asserted-by":"publisher","first-page":"e84020","DOI":"10.7759\/cureus.84020","volume":"17","author":"MM Alcal\u00e1","year":"2025","unstructured":"Alcal\u00e1 MM, Grany\u00f3 MA, Fern\u00e1ndez DG, et al. Local ablative treatment of the primary tumour in patients with metastatic breast cancer: a retrospective observational study. Cureus. 2025;17:e84020. https:\/\/doi.org\/10.7759\/cureus.84020.","journal-title":"Cureus."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20187-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:51:08Z","timestamp":1790916668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20187-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20187"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20187-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}